Evidence map›Paper›PMID 31077224›Full record

ArticleClinical epigenetics2019

ZBTB12 DNA methylation is associated with coagulation- and inflammation-related blood cell parameters: findings from the Moli-family cohort.

Fabrizia Noro, Francesco Gianfagna, Alessandro Gialluisi, Amalia De Curtis, Augusto Di Castelnuovo, Emanuela Napoleone, Chiara Cerletti, Maria Benedetta Donati, Giovanni de Gaetano, Marc F Hoylaerts and 3 more

Abstract read
In one paragraph

Article in Clinical epigenetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. TheFrontiers in immunology · 2023
    Article
  6. The association betweenFrontiers in cardiovascular medicine · 2022
    Article
  7. Epigenetics · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fabrizia NoroDepartment of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, IS, Italy.
Francesco GianfagnaDepartment of Medicine and Surgery, University of Insubria, Varese, Italy.
Alessandro GialluisiDepartment of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, IS, Italy.
Amalia De CurtisDepartment of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, IS, Italy.
Augusto Di CastelnuovoMediterranea Cardiocentro, Naples, Italy.
Emanuela Napoleone, Present address: Viale del Cimitero 20, 66054, Vasto, CH, Italy.
Chiara CerlettiDepartment of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, IS, Italy.
Maria Benedetta DonatiDepartment of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, IS, Italy.
Giovanni de GaetanoDepartment of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, IS, Italy.
Marc F HoylaertsDepartment of Cardiovascular Sciences, Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium.
Licia IacovielloDepartment of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, IS, Italy. licia.iacoviello@neuromed.it.
Benedetta IzziDepartment of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, IS, Italy.
Moli-family study Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundZinc finger and BTB domain-containing protein 12 (ZBTB12) is a predicted transcription factor with potential role in hematopoietic development. Recent evidence linked low methylation level of ZBTB12 exon1 to myocardial infarction (MI) risk. However, the role of ZBTB12 in the pathogenesis of MI and cardiovascular disease in general is not yet clarified. We investigated the relation between ZBTB12 methylation and several blood parameters related to cardio-cerebrovascular risk in an Italian family-based cohort.

resultsZBTB12 methylation was analyzed on white blood cells from the Moli-family cohort using the Sequenom EpiTYPER MassARRAY (Agena). A total of 13 CpG Sequenom units were analyzed in the small CpG island located in the only translated ZBTB12 exon. Principal component analysis (PCA) was performed to identify groups of CpG units with similar methylation estimates. Linear mixed effect regressions showed a positive association between methylation of ZBTB12 Factor 2 (including CpG units 8, 9-10, 16, 21) and TNF-ɑ stimulated procoagulant activity, a measure of procoagulant and inflammatory potential of blood cells. In addition, we also found a negative association between methylation of ZBTB12 Factor 1 (mainly characterized by CpG units 1, 3-4, 5, 11, and 26) and white blood cell and granulocyte counts. An in silico prediction analysis identified granulopoiesis- and hematopoiesis-specific transcription factors to potentially bind DNA sequences encompassing CpG1, CpG3-4, and CpG11.

conclusionsZBTB12 hypomethylation is linked to shorter TNF-ɑ stimulated whole blood coagulation time and increased WBC and granulocyte counts, further elucidating the possible link between ZBTB12 methylation and cardiovascular disease risk.

Indexed as

DNA MethylationAdultBlood CoagulationBlood Coagulation FactorsCohort StudiesCpG IslandsDNA-Binding ProteinsFemaleGranulocytesHumansLeukocyte CountMaleMiddle AgedMyocardial InfarctionPrincipal Component AnalysisTranscription FactorsBlood Coagulation FactorsDNA-Binding ProteinsTNF protein, humanTranscription FactorsTumor Necrosis Factor-alphaZBTB12 protein, humanCardiovascular riskDNA methylationGranulocyte countsWhite blood cell countsWhole blood coagulation timeZinc fingers

Identifiers

PMID31077224
PMCPMC6511189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.